Medicine - Hematology and Medical Oncology

411563 Citations
273 h-index
4406 Article
804 Review article
260 Letter
248 Comment/debate
More

1₈ F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation
Holter-Chakrabarty, J., McNally, L., Levine, J., Ferrara, J., Vesely, S. K., Kanakry, C. G., Garwe, T., Han, Z., Pandey, M., Glover, J., Wen, Y., Gress, R. & Williams, K. M., 2025, In: Radiology: Imaging Cancer. 7, 1, e240096.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
Sterling, R. K., Patel, K., Duarte-Rojo, A., Asrani, S. K., Alsawas, M., Dranoff, J. A., Fiel, M. I., Murad, M. H., Leung, D. H., Levine, D., Taddei, T. H., Taouli, B. & Rockey, D. C., 1 Jan 2025, In: Hepatology. 81, 1, p. 321-357 37 p.
Research output: Contribution to journal › Article › peer-review

70 Scopus citations
AASLD Practice Guideline on noninvasive liver disease assessment of portal hypertension
Sterling, R. K., Asrani, S. K., Levine, D., Duarte-Rojo, A., Patel, K., Fiel, M. I., Leung, D. H., Taouli, B., Alsawas, M., Murad, M. H., Dranoff, J. A., Taddei, T. H. & Rockey, D. C., 1 Mar 2025, In: Hepatology. 81, 3, p. 1060-1085 26 p.
Research output: Contribution to journal › Article › peer-review

21 Scopus citations
Abbreviated MRI for Hepatocellular Carcinoma Screening: A Comprehensive Review
Min, J. H., Kim, Y. K., Jeong, W. K. & Taouli, B., Dec 2025, In: Current Hepatology Reports. 24, 1, 18.
Research output: Contribution to journal › Review article › peer-review
Access to dermatologic care for cancer patients: employment of an oncodermatology referral system
Powers, C. M., Hu, B. D., Block, B. R., Piontkowski, A. J., Silver, C., Orloff, J., Young, J. N., Smith, C. B., Lamb, A. J. & Gulati, N., Mar 2025, In: Supportive Care in Cancer. 33, 3, 161.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Addition of Elotuzumab to Backbone Treatment Regimens for Multiple Myeloma: An Updated Meta-Analysis of Randomized Clinical Trials
Costa, B. A., Costa, T. A., Chagas, G. C. L., Mouhieddine, T. H., Richter, J., Usmani, S. Z., Mailankody, S., Rajeeve, S. & Hashmi, H., Jan 2025, In: Clinical Lymphoma, Myeloma and Leukemia. 25, 1, p. 32-44 13 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Adjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Colorectal Liver Metastases
Bokhoven, H., Fakih, M. G., Ang, C. & Koerkamp, B. G., 1 Jan 2025, Hepatic Arterial Infusion for Malignancy. Springer Science+Business Media, p. 177-190 14 p.
Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274
Galsky, M. D., Witjes, J. A., Gschwend, J. E., Milowsky, M. I., Schenker, M., Valderrama, B. P., Tomita, Y., Bamias, A., Lebret, T., Shariat, S. F., Park, S. H., Agerbaek, M., Jha, G., Stenner, F., Ye, D., Giudici, F., Dutta, S., Askelson, M., Nasroulah, F. & Zhang, J. & 2 others, Brophy, L. & Bajorin, D. F., 1 Jan 2025, In: Journal of Clinical Oncology. 43, 1, p. 15-21 7 p.
Research output: Contribution to journal › Article › peer-review

Open Access
47 Scopus citations
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial
Galsky, M. D., Bajorin, D. F., Tomita, Y., Ye, D., Agerbaek, M., Enting, D., Peer, A., Milowsky, M., Kobayashi, K., Grimm, M. O., Stenner, F., David, J. M., Li, J., Chasalow, S. D., Nasroulah, F., Apfel, A., Ünsal-Kaçmaz, K. & Necchi, A., Sep 2025, In: Nature Medicine. 31, 9, p. 3062-3073 12 p.
Research output: Contribution to journal › Article › peer-review

1 Scopus citations
Advancements in bispecific antibodies for multiple myeloma: What's new and what lies ahead
Mouhieddine, T. H., Costa, B. A. & Richter, J., Feb 2025, In: Seminars in Hematology. 62, 1, p. 58-70 13 p.
Research output: Contribution to journal › Article › peer-review
3 Scopus citations
A heterozygous CEBPA mutation disrupting the bZIP domain in a RUNX1 and SRSF2 mutational background causes MDS disease progression
Almaghrabi, R., Alyahyawi, Y., Keane, P., Mian, S. A., Habel, K., Atkinson, A., Ward, C., Bayley, R., Sargas, C., Menendez, P., Murphy, G. J., Sobahy, T., Baghdadi, M. A., Flemban, A. F., Kabrah, S. M., Torres-Ruiz, R., Papapetrou, E. P., Akerman, I., Raghavan, M. & Barragan, E. & 3 others, Bonnet, D., Bonifer, C. & Garcia, P., Dec 2025, In: Nature Communications. 16, 1, 5489.
Research output: Contribution to journal › Article › peer-review

Open Access
A Journey Through the Golden Era of Myeloma Treatment: From Bench to Bedside
Jagannath, S., May 2025, In: Clinical Lymphoma, Myeloma and Leukemia. 25, 5, p. 316-318 3 p.
Research output: Contribution to journal › Short survey › peer-review

The universities producing the most billionaires in the world, ranked
Curtis, S.
11/12/25
1 item of Media coverage
Press/Media
ECOG-ACRIN and Caris Life Sciences unveil first findings from a multi-year collaboration to advance AI-powered multimodal tools for breast cancer recurrence risk stratification
Sparano, J.
11/12/25
1 item of Media coverage
Press/Media
A Multimodal AI Model May Improve Recurrence Risk Stratification in Early Breast Cancer
Sparano, J.
10/12/25
3 items of Media coverage
Press/Media
Weekly Summary: Karyopharm Therapeutics (KPTI: $4.55) lifts 3.6%, 5 weeks' volume in a week; +16c [3.6%] Vol Index 5.0 [1 is avg]
Mascarenhas, J.
12/07/25
1 item of Media coverage
Press/Media
Research Leaders Across New York State Form Empire State Cellular Therapy Consortium
Osman, K.
10/07/25 → 11/07/25
20 items of Media coverage
Press/Media
How Regeneron's dividend compares to Its Peers - what Analysts are saying
Jagannath, S.
11/07/25
1 item of Media coverage
Press/Media
HarborOne Bancorp increases 4.9% in 2025, but lagging Bank sector
Frenette,, P.
11/07/25
1 item of Media coverage
Press/Media
Clinical Trial: A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation
Marron, T.
11/07/25
2 items of Media coverage
Press/Media
Regeneron continues to outperform Bristol Myers Squibb by 13.7% in the past month - what Analysts are saying
Jagannath, S.
11/07/25
1 item of Media coverage
Press/Media
Regeneron wipes off $17.5 billion (23%) in MCap in 2025, steepest loss in Medical/Biomedical sector
Jagannath, S.
11/07/25
1 item of Media coverage
Press/Media
Regeneron continues to outperform Pfizer by 4.0% in the past month - what Analysts are saying
Jagannath, S.
11/07/25
1 item of Media coverage
Press/Media
How Regeneron Has Fared Since Its Recent Analyst Ratings Changes - what Analysts are saying
Jagannath, S.
11/07/25
1 item of Media coverage
Press/Media